These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 12525660

  • 1. CD154 blockade results in transient reduction in Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Howard LM, Neville KL, Haynes LM, Dal Canto MC, Miller SD.
    J Virol; 2003 Feb; 77(3):2247-50. PubMed ID: 12525660
    [Abstract] [Full Text] [Related]

  • 2. The level of viral infection of antigen-presenting cells correlates with the level of development of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Jin YH, Kang HS, Hou W, Meng L, Kim BS.
    J Virol; 2015 Feb; 89(3):1867-78. PubMed ID: 25428872
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice.
    Katz-Levy Y, Neville KL, Girvin AM, Vanderlugt CL, Pope JG, Tan LJ, Miller SD.
    J Clin Invest; 1999 Sep; 104(5):599-610. PubMed ID: 10487774
    [Abstract] [Full Text] [Related]

  • 5. Clonal expansion of infiltrating T cells in the spinal cords of SJL/J mice infected with Theiler's virus.
    Kang JA, Mohindru M, Kang BS, Park SH, Kim BS.
    J Immunol; 2000 Jul 01; 165(1):583-90. PubMed ID: 10861099
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Anti-CCL2 treatment inhibits Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Karpus WJ, Kennedy KJ, Fife BT, Bennett JL, Dal Canto MC, Kunkel SL, Lukacs NW.
    J Neurovirol; 2006 Aug 01; 12(4):251-61. PubMed ID: 16966216
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cellular sources and targets of IFN-gamma-mediated protection against viral demyelination and neurological deficits.
    Murray PD, McGavern DB, Pease LR, Rodriguez M.
    Eur J Immunol; 2002 Mar 01; 32(3):606-15. PubMed ID: 11857334
    [Abstract] [Full Text] [Related]

  • 11. Temporal development of autoreactive Th1 responses and endogenous presentation of self myelin epitopes by central nervous system-resident APCs in Theiler's virus-infected mice.
    Katz-Levy Y, Neville KL, Padilla J, Rahbe S, Begolka WS, Girvin AM, Olson JK, Vanderlugt CL, Miller SD.
    J Immunol; 2000 Nov 01; 165(9):5304-14. PubMed ID: 11046065
    [Abstract] [Full Text] [Related]

  • 12. Differential expression of TGF-beta, IL-2, and other cytokines in the CNS of Theiler's murine encephalomyelitis virus-infected susceptible and resistant strains of mice.
    Chang JR, Zaczynska E, Katsetos CD, Platsoucas CD, Oleszak EL.
    Virology; 2000 Dec 20; 278(2):346-60. PubMed ID: 11118358
    [Abstract] [Full Text] [Related]

  • 13. Contrasting effects of anti-adhesion molecule therapy in experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis.
    Rose JW, Welsh CT, Hill KE, Houtchens MK, Fujinami RS, Townsend JJ.
    J Neuroimmunol; 1999 Jun 01; 97(1-2):110-8. PubMed ID: 10408964
    [Abstract] [Full Text] [Related]

  • 14. Gamma interferon is critical for neuronal viral clearance and protection in a susceptible mouse strain following early intracranial Theiler's murine encephalomyelitis virus infection.
    Rodriguez M, Zoecklein LJ, Howe CL, Pavelko KD, Gamez JD, Nakane S, Papke LM.
    J Virol; 2003 Nov 01; 77(22):12252-65. PubMed ID: 14581562
    [Abstract] [Full Text] [Related]

  • 15. Potential role of CD4+ T cell-mediated apoptosis of activated astrocytes in Theiler's virus-induced demyelination.
    Palma JP, Yauch RL, Lang S, Kim BS.
    J Immunol; 1999 Jun 01; 162(11):6543-51. PubMed ID: 10352270
    [Abstract] [Full Text] [Related]

  • 16. High-dose mouse immunoglobulin G administration suppresses Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Koh C, Inoue A, Yamazaki M, Kim BS.
    J Neuroimmunol; 2000 Aug 01; 108(1-2):22-8. PubMed ID: 10900333
    [Abstract] [Full Text] [Related]

  • 17. Transition from acute to persistent Theiler's virus infection requires active viral replication that drives proinflammatory cytokine expression and chronic demyelinating disease.
    Trottier M, Schlitt BP, Kung AY, Lipton HL.
    J Virol; 2004 Nov 01; 78(22):12480-8. PubMed ID: 15507635
    [Abstract] [Full Text] [Related]

  • 18. The majority of infiltrating CD8+ T cells in the central nervous system of susceptible SJL/J mice infected with Theiler's virus are virus specific and fully functional.
    Kang BS, Lyman MA, Kim BS.
    J Virol; 2002 Jul 01; 76(13):6577-85. PubMed ID: 12050370
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.